Related Experiment Videos
EST 0469B--comparison of high- and low-dose cyclophosphamide in human lung cancer
Medical and Pediatric Oncology
|January 1, 1978
Abstract:
A controlled trial of high-intermittent vs low-chronic dose cyclophosphamide in human lung cancer failed to show the benefits reported in noncontrolled trials. There were no differences in toxicity observed.